Medac Pharma, Inc. is a privately held specialty pharmaceutical company based in Chicago, Illinois. Backed by medac GmbH, a global pharmaceutical company that has been operating in 70 countries for over 40 years, they are independently and aggressively building their operations in the United States, focusing initially on the development and commercialization of treatments for autoimmune diseases and cancer. By forming new partnerships and leveraging their parent company’s strong product pipeline, they have the opportunity to make significant medical advancements that can help patients live better lives.
Personalized approach to medicine
Their team is dedicated to developing and commercializing medicines that offer the highest possible degree of safety and tolerability. They develop mid-to-late stage molecules as well as enhance existing therapies through new dosage forms, concentrations, and modes of delivery. They believe in taking a personalized approach to medicine, where patients have access to the best treatment options and the ability to manage their own therapy.
For more information about Medac Pharma, click here.